tert-butyl 2-(chloromethyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxylate

tert-butyl 2-(chloromethyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxylate Struktur
2306263-07-8
CAS-Nr.
2306263-07-8
Englisch Name:
tert-butyl 2-(chloromethyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxylate
Synonyma:
tert-butyl 2-(chloromethyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxylate;Imidazo[1,2-a]pyrazine-7(8H)-carboxylic acid, 2-(chloromethyl)-5,6-dihydro-, 1,1-dimethylethyl ester
CBNumber:
CB48232852
Summenformel:
C12H18ClN3O2
Molgewicht:
271.74
MOL-Datei:
2306263-07-8.mol

tert-butyl 2-(chloromethyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxylate Eigenschaften

Siedepunkt:
443.9±40.0 °C(Predicted)
Dichte
1.28±0.1 g/cm3(Predicted)
pka
6.42±0.20(Predicted)

Sicherheit

tert-butyl 2-(chloromethyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxylate Chemische Eigenschaften,Einsatz,Produktion Methoden

tert-butyl 2-(chloromethyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxylate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


tert-butyl 2-(chloromethyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxylate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 5)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Blocksynth Pharmaceutical Technology Co.,Ltd
0086-19817745290; +8619817745290
bd@blocksynth.com China 5660 58
Suzhou ARTK Medchem Co., Ltd.
+86-512-68323658 +86-18168183658
sales1@artkmedchem.com China 39010 58
Suzhou Rovathin Foreign Trade Co.,Ltd 0512-65816829 18662214788
info@rovathin.com.cn China 9582 58
PharmaBlock Sciences (Nanjing), Inc. 4000255188 4000255188
sales@pharmablock.com China 7268 58
Ningbo Zhenyue Pharmaceutical Technology Co., Ltd 19817745290
bd@blocksynth.com China 5643 58

  • tert-butyl 2-(chloromethyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxylate
  • Imidazo[1,2-a]pyrazine-7(8H)-carboxylic acid, 2-(chloromethyl)-5,6-dihydro-, 1,1-dimethylethyl ester
  • 2306263-07-8
Copyright 2019 © ChemicalBook. All rights reserved